We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.

Despite sky-high valuations, Jun Bei Liu is bullish on Pro Medicus. She first bought at $25 - now it’s 10x’d. How much higher ...

Welcome to the second weekly report for the February 2025 results season. The FNArena Reporting Season Monitor reports ...

Yarra Capital's Roy Keenan is a fixed income tragic, with 40+ years in the chair. Here, he shares his take on today's key ...

A new year with old themes. Strong absolute returns and the stocks which have benefited most from multiple divergence in 2024 ...

When it comes to investing in gold, many investors are faced with a choice: physical gold or gold mining stocks. While both ...

Earnings may have bottomed out and there's hope in the air this reporting season, according to FNArena's Rudi Filapek-Vandyck ...

Earnings season divides winners and losers as rate cut bets shift and US inflation rattles markets.

AI is a long-term growth story which will support the global economy and provide a wide range of potential investment ...

Here's a list you can use to identify Australian suburbs with a high probability of outperforming median property prices.

In this wire, Pzena Investment Management share where they find value-oriented opportunities in a mega cap-driven market.

This episode is all about Telstra ( ASX: TLS ), Australia’s leading telecommunications provider which has over 50% market ...